Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (271-280 of 304) with videos related to

Pageof 31
Sort By:
Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.
Cancer Research|August 1, 1982
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress reportR C Coombes, C Chilvers, M Dowsett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancerL R Kelland, V Smith, M Valenti, et al.
Cancer Research|January 15, 1994
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancerD J DeFriend, A Howell, R I Nicholson, et al.
The Journal of Pathology|March 14, 2003
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centresM Dowsett, J Bartlett, I O Ellis, et al.
British Journal of Cancer|February 1, 1996
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancerH R Bonnefoi, I E Smith, M Dowsett, et al.
Breast Cancer Research and Treatment|October 1, 1989
Chemoprevention of breast cancerT J Powles, J R Hardy, S E Ashley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapyA Sheri, I E Smith, S R Johnston, et al.
Lancet (London, England)|August 2, 2011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, C Davies, J Godwin, et al.
British Journal of Cancer|September 11, 2003
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancerC D Archer, M Parton, I E Smith, et al.
Pageof 31

Showing results (271-280 of 304) with videos related to

Sort By:
Pageof 31
Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.
Cancer Research|August 1, 1982
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress reportR C Coombes, C Chilvers, M Dowsett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancerL R Kelland, V Smith, M Valenti, et al.
Cancer Research|January 15, 1994
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancerD J DeFriend, A Howell, R I Nicholson, et al.
The Journal of Pathology|March 14, 2003
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centresM Dowsett, J Bartlett, I O Ellis, et al.
British Journal of Cancer|February 1, 1996
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancerH R Bonnefoi, I E Smith, M Dowsett, et al.
Breast Cancer Research and Treatment|October 1, 1989
Chemoprevention of breast cancerT J Powles, J R Hardy, S E Ashley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapyA Sheri, I E Smith, S R Johnston, et al.
Lancet (London, England)|August 2, 2011
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, C Davies, J Godwin, et al.
British Journal of Cancer|September 11, 2003
Early changes in apoptosis and proliferation following primary chemotherapy for breast cancerC D Archer, M Parton, I E Smith, et al.
Pageof 31